The post MORPHO Technical Analysis Feb 10 appeared on BitcoinEthereumNews.com. MORPHO, at its current price of 1.14$, is trading very close to the critical supportThe post MORPHO Technical Analysis Feb 10 appeared on BitcoinEthereumNews.com. MORPHO, at its current price of 1.14$, is trading very close to the critical support

MORPHO Technical Analysis Feb 10

MORPHO, at its current price of 1.14$, is trading very close to the critical support zone at 1.1010$ and showing weakness signals in the downtrend. Strong selling pressure is expected at the nearby resistance level of 1.1580$, with high liquidity sweep potential.

Current Price Position and Critical Levels

MORPHO’s current price is positioned at 1.14$, having traded in the 1.10$-1.17$ range with a 1.89% decline over the last 24 hours. The overall trend is downward, with the price remaining below EMA20 (1.18$), which gives a short-term bearish signal. RSI at 45.73 is in the neutral zone, while the Supertrend indicator is bearish and pointing to the 1.44$ resistance. Multi-timeframe (MTF) analysis identified a total of 11 strong levels across 1D, 3D, and 1W charts: 1D with 2 supports/2 resistances, 3D with 1 support/2 resistances, 1W with 3 supports/2 resistance confluences. With the price near the primary support at 1.1010$, a break below here could lead to deeper corrections. Volume is low at 6.97M$, indicating that big players are holding their positions. The current price position signals a liquidity accumulation phase; buyers are defending at support, while sellers dominate at resistances.

Support Levels: Buyer Zones

Primary Support

The 1.1010$ level (strength score: 74/100) stands out as MORPHO’s most critical buyer zone. This level coincides with an order block from the recent lows (nearby 1.10$ base) on the 1D chart and is confirmed as a strong demand zone on the 3D timeframe. Historically, the price has tested this zone three times, producing 5-8% bounces each time; for example, during the December 2025 test, it was rejected with a 40% volume increase. Its alignment with the 1W EMA50 (around 1.10) in MTF confluence makes it an area where institutional buyers accumulate liquidity. According to volume profile analysis, there is high trading volume accumulation in this zone, meaning positive delta – buyers are dominant. Long wicks should be expected as price approaches here; in case of a breakout, monitor below 1.09$ for invalidation.

Secondary Support and Stop Levels

The secondary support at 0.9881$ (score: 67/100) functions as a deeper demand pool. This level is at the confluence of the 1W Fibonacci 0.618 retracement and the 3D swing low. In historical tests (before the September 2025 rally), the price bounced 20% from here, supported by a volume surge. Its overlap with EMA200 (around 0.99$) indicates it’s an entry point for long-term buyers. As a stop level, monitor below 0.9881$ at 0.97$; a break here would signal a trend change, activating the 0.4719$ downside target. From a liquidity perspective, there is high stop hunt potential below this zone – it could clear out small traders’ liquidity.

Resistance Levels: Seller Zones

Near-Term Resistances

1.1580$ (score: 66/100) is the nearest short-term seller zone, aligned with the 24-hour high (1.17$). On the 1D chart, this level is defined as the lower boundary of a bearish order block; the price has hit it twice and been rejected, showing increased selling volume with upper wicks. Close confluence with EMA20 (1.18$) supports continuation of the short-term trend. This is the first test point before Supertrend’s main 1.44$ resistance; clean volume is required for a breakout, otherwise there’s fakeout risk. Historical volume spikes confirm concentrated institutional selling here.

Main Resistance and Targets

1.2363$ (score: 61/100) is the main resistance and potential target zone. This level is marked by supply imbalance on 3D/1W timeframes; it fills a fair value gap from the October 2025 peak. A clean breakout above 1.1580$ is required for price to reach here, otherwise rejection is expected. Higher up, monitor Supertrend resistance at 1.44$ and upside target at 2.0018$ (low score but near ATH). At these resistances, imbalances act as liquidity draw points – big players could close shorts from here. Closing below 1.20$ is critical for breakout invalidation.

Liquidity Map and Big Players

MORPHO’s liquidity map shows concentrated stop clusters below the 1.1010$ support and above the 1.1580$ resistance. Big players (whales) are likely defending their longs at the 1.1010$ order block while accumulating shorts in the 1.2363$ supply zone. Volume delta analysis indicates buyers hiding during low-volume declines – ideal for sweep and reverse setups. The 1W’s 3 support confluences draw excess liquidity, making price volatile; upside rotation is possible after downside liquidity grab. Overall, sellers are superior in the downtrend, but look for reversal signals on support tests.

Bitcoin Correlation

Altcoins like MORPHO move with 80% correlation to BTC; BTC is currently in a downtrend at 69,590$ with critical supports at 68,399$-62,910$. While BTC’s Supertrend gives a bearish signal, pressure increases on altcoins – MORPHO’s 1.1010$ support can be defended if BTC holds above 68k. If BTC resistances at 70,496$-73,869$ break, MORPHO could test 1.1580$; rising dominance increases downside risk. If BTC slips below 62k, it triggers a liquidity hunt toward MORPHO’s 0.9881$. Key: Monitor BTC key levels; correlation breaks create opportunities.

Trading Plan and Level-Based Strategy

Level-based outlook: Holding above 1.1010$ targets 1.1580$ short-term (R/R 1:2 potential); breakout targets 0.9881$ downside. In upside scenario, target 1.2363$, but EMA20 breakout required. Risk management: 1-2% stops, wait for MTF confirmation. For detailed spot analysis, check MORPHO Spot Analysis; for futures, MORPHO Futures Analysis. This outlook is price action based; markets are variable.

This analysis uses Chief Analyst Devrim Cacal’s market views and methodology.

Crypto Research Analyst: Michael Roberts

Blockchain technology and DeFi focused

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/morpho-technical-analysis-february-10-2026-support-and-resistance-levels

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0005645
$0.0005645$0.0005645
+20.54%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26